Theralase Technologies uses Virginia Tech research to successfully destroy breast cancer cells

Simple item page
dc.contributor.authorDoss, Catherineen
dc.coverage.spatialBlacksburg, Va.en
dc.date.accessioned2015-10-29T21:40:45Zen
dc.date.available2015-10-29T21:40:45Zen
dc.date.issued2010-01-25en
dc.description.abstractCompounds developed by researchers at Virginia Tech, have proven effective in destroying breast cancer cells when used with lasers developed by Theralase Technologies (TSX-V: TLT) out of Toronto. Theralase, an international manufacturer of laser medical devices, reports that its patented photodynamic compounds (PDCs) developed at the university, when used with its lasers, destroy breast cancer cells in pre-clinical trials.en
dc.identifier.urihttp://hdl.handle.net/10919/63182en
dc.publisherVirginia Tech. University Relationsen
dc.rightsIn Copyrighten
dc.rights.holderVirginia Tech. University Relationsen
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjectCollege of Scienceen
dc.titleTheralase Technologies uses Virginia Tech research to successfully destroy breast cancer cellsen
dc.typePress releaseen
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 1 of 1
Name:
2010-45.html
Size:
6.06 KB
Format:
Hypertext Markup Language
Download

Collections

Virginia Tech News